In conclusion, our findings provide initial evidence suggesting that NR4A3 suppresses HCC cell proliferation by regulating levels of CDKN2AIP expression, thereby playing a pivotal role as a tumor suppressor during HCC progression both in vitro and in vivo settings. The gene discussed is CDKN2AIP; the disease is neoplasm.